January 9, 2020 / 11:05 PM / 13 days ago

Fed Circuit rules against Pfizer in sedative patent dispute

A federal appeals court Thursday upheld a patent ruling that allowed healthcare company Fresenius Kabi to launch a generic version of Pfizer Inc’s sedative Precedex Premix.

A three-judge panel of the U.S. Court of Appeals for the Federal Circuit affirmed a lower court judge’s ruling that invalidated on obviousness grounds a key claim in a patent owned by Pfizer’s Hospira unit covering Precedex Premix’s formulation.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/36L9GWw

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below